{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:19:16Z","timestamp":1768076356328,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Philips Healthcare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and objectives<\/jats:title>\n                <jats:p>There is a need for robust antibiotic stewardship programs (ASPs) in the neonatal population. This study's objectives were to assess neonatal antibiotic use practices over an extended period across an integrated delivery network (IDN), including six Neonatal Intensive Care Units (NICUs), to identify those most successful practices reducing use rates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted, including 15,015 NICU admissions from an integrated delivery network, across six hospitals over eight years (50% Level III and 50% Level II) computing antibiotic use rates (AURs) stratified by usage: in the first few days of the stay vs. later in the stay and by gestational age. Several metrics were examined for assumptions of strong correlation with AUR: (1) the percentage of infants given antibiotics early in their stays and (2) durations of courses of antibiotics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results conclude a wide variation in AURs and trends that these rates followed over time. However, there was a decrease in overall AUR from 15.7\u201316.6 to 10.1\u201310.8%, with four of the six NICUs recording statistically significant reductions in AUR vs. their first year of measurement. Specifically, the level III NICUs overall AUR decreases from 15.1\u201316.22 to 8.6\u20139.4%, and level II NICUs overall AUR 20.3\u201324.4 to 14.1\u201316.1%. A particularly successful level II NICU decreased its AUR from 22.9\u201330.6 to 5.9\u20139.4%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>To our knowledge, this is the first study to utilize data analytics at an IDN level to identify trends in AUR, We have identified practices that allowed an institution to reduce NICU AURs significantly, and which, if done as a standard practice, could be replicated on a broader scale.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01057-3","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T13:03:13Z","timestamp":1643634193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neonatal ICU antibiotic use trends within an integrated delivery network"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7223-3714","authenticated-orcid":false,"given":"Gregory","family":"Boverman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Vij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Tgavalekos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyas","family":"Ravindranath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornel","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobbi","family":"Chambers-Hawk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"1057_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkx426","volume":"73","author":"JW Fjalstad","year":"2018","unstructured":"Fjalstad JW, Esaiassen E, Juvet LK, et al. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother. 2018;73:569\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"1057_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7196\/SAMJ.9644","volume":"105","author":"M Mendelson","year":"2015","unstructured":"Mendelson M, Matsoso MP. The World Health Organization global action plan for antimicrobial resistance. SAMJ South Afr Med J. 2015;105:325\u2013325.","journal-title":"SAMJ South Afr Med J"},{"key":"1057_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","volume":"387","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168\u201375.","journal-title":"Lancet"},{"key":"1057_CR4","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1542\/peds.2005-1707","volume":"117","author":"RH Clark","year":"2006","unstructured":"Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. J Pediatr. 2006;117:1979\u201387.","journal-title":"J Pediatr"},{"key":"1057_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.paed.2019.03.004","volume":"29","author":"AA Chakkarapani","year":"2019","unstructured":"Chakkarapani AA, Russell AB. Antibiotic stewardship in the neonatal intensive care unit. J Paediatr Child Health. 2019;29:269\u201373.","journal-title":"J Paediatr Child Health"},{"key":"1057_CR6","doi-asserted-by":"publisher","first-page":"e20182894","DOI":"10.1542\/peds.2018-2894","volume":"142","author":"KM Puopolo","year":"2018","unstructured":"Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of neonates born at \u2265 35 0\/7 weeks\u2019 gestation with suspected or proven early-onset bacterial sepsis. J Pediatr. 2018;142:e20182894. https:\/\/doi.org\/10.1542\/peds.2018-2894.","journal-title":"J Pediatr"},{"key":"1057_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jamapediatrics.2016.2132","volume":"170","author":"JY Ting","year":"2016","unstructured":"Ting JY, Synnes A, Roberts A, et al. Association between antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis. JAMA Pediatr. 2016;170:1181\u20137.","journal-title":"JAMA Pediatr"},{"key":"1057_CR8","doi-asserted-by":"publisher","first-page":"e20182286","DOI":"10.1542\/peds.2018-2286","volume":"143","author":"JY Ting","year":"2019","unstructured":"Ting JY, Roberts A, Sherlock R, et al. Duration of initial empirical antibiotic therapy and outcomes in very low birth weight infants. J Pediatr. 2019;143:e20182286. https:\/\/doi.org\/10.1542\/peds.2018-2286.","journal-title":"J Pediatr"},{"key":"1057_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpeds.2018.07.036","volume":"203","author":"JB Cantey","year":"2018","unstructured":"Cantey JB, Pyle AK, Wozniak PS, et al. Early antibiotic exposure and adverse outcomes in preterm, very low birth weight infants. J Pediatr. 2018;203:62\u20137.","journal-title":"J Pediatr"},{"key":"1057_CR10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dkx088","volume":"72","author":"E Esaiassen","year":"2017","unstructured":"Esaiassen E, Fjalstad JW, Juvet LK, et al. Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis. J Antimicrob Chemother. 2017;72:1858\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"1057_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MOP.0000000000000338","volume":"28","author":"CM Cotten","year":"2016","unstructured":"Cotten CM. Adverse consequences of neonatal antibiotic exposure. Curr Opin Pediatr. 2016;28:141.","journal-title":"Curr Opin Pediatr"},{"issue":"6285","key":"1057_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","volume":"352","author":"T Gensollen","year":"2016","unstructured":"Gensollen T, Iyer SS, Kasper DL, et al. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539\u201344.","journal-title":"Science"},{"issue":"6","key":"1057_CR13","doi-asserted-by":"publisher","first-page":"e180315","DOI":"10.1001\/jamapediatrics.2018.0315","volume":"172","author":"E Mitre","year":"2018","unstructured":"Mitre E, Susi A, Kropp LE, et al. Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood. JAMA Pediatr. 2018;172(6):e180315. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0315.","journal-title":"JAMA Pediatr"},{"key":"1057_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fendo.2017.00170","volume":"20","author":"X Shao","year":"2017","unstructured":"Shao X, Ding X, Wang B, et al. Antibiotic exposure in early life increases risk of childhood obesity: a systematic review and meta-analysis. Front Endocrinol. 2017;20:8. https:\/\/doi.org\/10.3389\/fendo.2017.00170.","journal-title":"Front Endocrinol"},{"issue":"10","key":"1057_CR15","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51\u201377. https:\/\/doi.org\/10.1093\/cid\/ciw118.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1057_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/INF.0b013e3182011d12","volume":"30","author":"CH Chiu","year":"2011","unstructured":"Chiu CH, Michelow IC, Cronin J, et al. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. J Pediatr Infect Dis. 2011;30(4):273\u20138.","journal-title":"J Pediatr Infect Dis"},{"issue":"3","key":"1057_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/PCC.0000000000000615","volume":"17","author":"KR Lee","year":"2016","unstructured":"Lee KR, Bagga B, Arnold SR. Reduction of broad-spectrum antimicrobial use in a tertiary children\u2019s hospital post antimicrobial stewardship program guideline implementation. Pediatr Crit Care Med. 2016;17(3):187\u201393.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"1057_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4081\/idr.2017.6829","volume":"9","author":"N Beerlage-de Jong","year":"2017","unstructured":"Beerlage-de Jong N, Van Gemert-Pijnen L, Wentzel J, et al. Technology to support integrated antimicrobial stewardship programs: a user centered, and stakeholder driven development approach. Infect Dis Rep. 2017;9(1):36\u201341.","journal-title":"Infect Dis Rep"},{"issue":"2","key":"1057_CR19","doi-asserted-by":"publisher","first-page":"e000285","DOI":"10.1136\/bmjoq-2017-000285","volume":"7","author":"V Makri","year":"2018","unstructured":"Makri V, Davies G, Cannell S, et al. Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK. BMJ Open Qual. 2018;7(2):e000285. https:\/\/doi.org\/10.1136\/bmjoq-2017-000285.","journal-title":"BMJ Open Qual"},{"issue":"1","key":"1057_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/CCM.0000000000003463","volume":"47","author":"C Lu","year":"2019","unstructured":"Lu C, Liu Q, Yuan H, et al. Implementation of the smart use of antibiotics program to reduce unnecessary antibiotic use in a neonatal ICU: a prospective interrupted time-series study in a developing country. Crit Care Med. 2019;47(1):e1\u20137. https:\/\/doi.org\/10.1097\/CCM.0000000000003463.","journal-title":"Crit Care Med"},{"issue":"6","key":"1057_CR21","doi-asserted-by":"publisher","first-page":"e20174322","DOI":"10.1542\/peds.2017-4322","volume":"142","author":"T Ho","year":"2018","unstructured":"Ho T, Buus-Frank ME, Edwards E, et al. Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations. Pediatrics. 2018;142(6):e20174322. https:\/\/doi.org\/10.1542\/peds.2017-4322.","journal-title":"Pediatrics"},{"issue":"5","key":"1057_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1542\/peds.2014-3409","volume":"135","author":"J Schulman","year":"2015","unstructured":"Schulman J, Dimand RJ, Lee HC, et al. Neonatal intensive care unit antibiotic use. Pediatrics. 2015;135(5):826\u201333.","journal-title":"Pediatrics"},{"issue":"4","key":"1057_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamapediatrics.2016.4678","volume":"171","author":"MW Kuzniewicz","year":"2017","unstructured":"Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171(4):365\u201371.","journal-title":"JAMA Pediatr"},{"issue":"11","key":"1057_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/jamapediatrics.2019.2825","volume":"173","author":"NB Achten","year":"2019","unstructured":"Achten NB, Klingenberg C, Benitz WE, et al. Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(11):1032\u201340.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"1057_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/INF.0000000000002182","volume":"38","author":"NUR Durrani","year":"2019","unstructured":"Durrani NUR, Rochow N, Alghamdi J, et al. Minimum duration of antibiotic treatment based on blood culture in rule out neonatal sepsis. J Pediatr Infect Dis. 2019;38(5):528\u201332.","journal-title":"J Pediatr Infect Dis"},{"issue":"1","key":"1057_CR26","doi-asserted-by":"publisher","first-page":"e000643","DOI":"10.1136\/bmjpo-2020-000643","volume":"4","author":"B McMullan","year":"2020","unstructured":"McMullan B, Cooper C, Spotswood N, et al. Antibiotic prescribing in neonatal sepsis: an Australian nationwide survey. BMJ Paediatr Open. 2020;4(1):e000643. https:\/\/doi.org\/10.1136\/bmjpo-2020-000643.","journal-title":"BMJ Paediatr Open"},{"key":"1057_CR27","unstructured":"Centers for Disease Control and Prevention. The core elements of hospital antibiotic stewardship programs 2019. Atlanta (GA): Centers for Disease Control and Prevention (USA) [Internet] [updated 2019 cited 2021 September 24]. Available from: https:\/\/www.cdc.gov\/antibiotic-use\/healthcare\/pdfs\/hospital-core-elements-H.pdf."},{"issue":"4","key":"1057_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/jpids\/piy043","volume":"8","author":"MC Astorga","year":"2019","unstructured":"Astorga MC, Piscitello KJ, Menda N, et al. Antibiotic stewardship in the neonatal intensive care unit: effects of an automatic 48-hour antibiotic stop order on antibiotic use. J Pediatric Infect Dis Soc. 2019;8(4):310\u20136.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"6","key":"1057_CR29","doi-asserted-by":"publisher","first-page":"e20190589","DOI":"10.1542\/peds.2019-0589","volume":"144","author":"D Dukhovny","year":"2019","unstructured":"Dukhovny D, Buus-Frank ME, Edwards E, et al. A collaborative multicenter QI initiative to improve antibiotic stewardship in newborns. Pediatrics. 2019;144(6):e20190589. https:\/\/doi.org\/10.1542\/peds.2019-0589.","journal-title":"Pediatrics"},{"key":"1057_CR30","unstructured":"World Health Organization. Antimicrobial resistance. [Internet] [updated 2021 cited 2021 September 2024]. Available from: https:\/\/www.who.int\/health-topics\/antimicrobial-resistance."},{"key":"1057_CR31","doi-asserted-by":"crossref","unstructured":"ARPEC Project Group, Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, et al. High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the antibiotic resistance and prescribing in European Children Point Prevalence Survey. J Pediatric Infect Dis Soc. 2019;8(2):143\u2013151.","DOI":"10.1093\/jpids\/piy019"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01057-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T13:27:55Z","timestamp":1643635675000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01057-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01057-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The hospital patient data we used in the study were anonymized to parameters agreed by the governance of Philips Research and Banner Healthcare. As the study comprised solely of retrospective data collected by Banner Healthcare, a waiver of informed consent was obtained from the institutional research board (IRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable due to have only data in aggregated form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Greg Boverman, Christine Perez, Kristen Tgavalekos, and Shreyas Ravindranath disclose that they are employees of Philips Healthcare, a medical device manufacturer. Dr. Cornel Antonescu and Dr. Bobbi Chambers-Hawk have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}